US Broker Ratings

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a 6.48% Upside in the Burgeoning Pain Management Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is positioned as a standout player in the healthcare sector, specifically among drug manufacturers specializing in specialty and generic medications. With..

RadNet, Inc. (RDNT) Stock Analysis: A 19.76% Potential Upside Beckons Investors in Healthcare Innovation

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry with its cutting-edge imaging services and..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 26% Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (RYTM), a leader in the biotechnology sector, has captured the attention of investors with its focus on rare neuroendocrine diseases. With a market..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 22% Potential Upside in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the development and manufacturing of medical devices. With a market capitalization of..

Glaukos Corporation (GKOS): Exploring a 33.84% Upside Potential in the Medical Device Sector

Glaukos Corporation (NYSE: GKOS) is positioning itself as a compelling opportunity within the medical device sector, particularly for investors seeking exposure to innovative healthcare technologies. Headquartered..

Akero Therapeutics, Inc. (AKRO) Investor Outlook: Navigating a 3.23% Upside in the Dynamic Biotech Sector

Akero Therapeutics, Inc. (NASDAQ: AKRO) operates at the cutting edge of the biotechnology industry, with an emphasis on developing innovative treatments for serious metabolic diseases. With..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unlocking a 21% Potential Upside in Healthcare Innovation

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector under the Medical Instruments & Supplies industry, is capturing investor attention with its..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 101% Upside in the Biotechnology Sector

Investors with an eye on the biotechnology sector should take a closer look at Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage vaccine innovation company with a market..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a Potential 42.86% Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a noteworthy player within the biotechnology sector, making waves with its innovative approach to treating B-cell mediated diseases. With..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 75% Upside Potential in the Biotechnology Sphere

ADMA Biologics Inc (NASDAQ: ADMA) stands at the intersection of innovation and healthcare, focusing on the biotechnology sector to deliver cutting-edge plasma-derived biologics. With a market..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector

Teleflex Incorporated (TFX), a stalwart in the healthcare sector, commands the attention of investors with its robust portfolio of single-use medical devices. Despite a challenging year..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a 23.67% Potential Upside in the Healthcare Sector

In the dynamic landscape of medical technology, Inspire Medical Systems, Inc. (NASDAQ: INSP) is a standout player. With a focus on providing innovative solutions for obstructive..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Exploring a 28.75% Potential Upside in the Medical Device Sector

For investors seeking opportunities in the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) offers a compelling case with its innovative approach to cardiac monitoring. This San..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking the 124.5% Return on Equity and Growth Potential

In the dynamic landscape of biotechnology, Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out with a commanding presence, bolstered by its significant achievements and promising growth metrics...

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Growth with a 6.62% Potential Upside

Investors interested in the healthcare sector may find Bausch + Lomb Corporation (NYSE: BLCO) an intriguing prospect, especially with its potential upside of 6.62% based on..

Telix Pharmaceuticals (TLX) Stock Analysis: Unveiling a 123.51% Potential Upside in Biotechnology

Telix Pharmaceuticals Limited (ASX: TLX), a standout in the biotechnology sector, has captured investor attention with its promising pipeline and a jaw-dropping potential upside of 123.51%...

Revolution Medicines, Inc. (RVMD): Investor Outlook on Its 19.48% Upside Potential

Revolution Medicines, Inc. (RVMD), a clinical-stage biotechnology firm specializing in precision oncology, has been making significant strides in the treatment of RAS-addicted cancers. Headquartered in Redwood..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring Its 24.25% Upside Potential

As the healthcare industry continues to evolve, Option Care Health, Inc. (NASDAQ: OPCH) stands out as a key player in the medical care facilities sector. Headquartered..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A 23% Potential Upside in Healthcare Innovation

BrightSpring Health Services, Inc. (BTSG) is garnering significant attention from investors eager to capitalize on its innovative approach within the healthcare sector. With a robust presence..

Waters Corporation (WAT) Investor Outlook: Analytical Solutions Leader with Solid Growth and Potential Upside

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, stands as a formidable entity in the diagnostics and research industry. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds